373 related articles for article (PubMed ID: 28576280)
21. Peripheral arterial disease in heterozygous familial hypercholesterolemia.
Pereira C; Miname MH; Makdisse MR; Watanabe C; Pesaro AE; Jannes CE; Kalil Filho R; Pereira AC; Santos RD
Atherosclerosis; 2015 Sep; 242(1):174-8. PubMed ID: 26201001
[TBL] [Abstract][Full Text] [Related]
22. Familial hypercholesterolemia: is it time to separate monogenic from polygenic familial hypercholesterolemia?
Brandts J; Dharmayat KI; Ray KK; Vallejo-Vaz AJ
Curr Opin Lipidol; 2020 Jun; 31(3):111-118. PubMed ID: 32332432
[TBL] [Abstract][Full Text] [Related]
23. Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers.
Besseling J; Kindt I; Hof M; Kastelein JJ; Hutten BA; Hovingh GK
Atherosclerosis; 2014 Mar; 233(1):219-23. PubMed ID: 24529147
[TBL] [Abstract][Full Text] [Related]
24. Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events.
D'Erasmo L; Minicocci I; Di Costanzo A; Pigna G; Commodari D; Ceci F; Montali A; Brancato F; Stanca I; Nicolucci A; Ascione A; Galea N; Carbone I; Francone M; Maranghi M; Arca M
J Am Heart Assoc; 2021 May; 10(9):e018932. PubMed ID: 33890476
[TBL] [Abstract][Full Text] [Related]
25. Value of the Definition of Severe Familial Hypercholesterolemia for Stratification of Heterozygous Patients.
Pérez-Calahorra S; Sánchez-Hernández RM; Plana N; Marco-Benedi V; Pedro-Botet J; Almagro F; Brea A; Ascaso JF; Lahoz C; Civeira F;
Am J Cardiol; 2017 Mar; 119(5):742-748. PubMed ID: 28081939
[TBL] [Abstract][Full Text] [Related]
26. Cascade screening for familial hypercholesterolemia: Practical consequences.
Louter L; Defesche J; Roeters van Lennep J
Atheroscler Suppl; 2017 Nov; 30():77-85. PubMed ID: 29096865
[TBL] [Abstract][Full Text] [Related]
27. Familial hypercholesterolemia--epidemiology, diagnosis, and screening.
Singh S; Bittner V
Curr Atheroscler Rep; 2015; 17(2):482. PubMed ID: 25612857
[TBL] [Abstract][Full Text] [Related]
28. Clinical phenotype in relation to the distance-to-index-patient in familial hypercholesterolemia.
Besseling J; Huijgen R; Martin SS; Hutten BA; Kastelein JJ; Hovingh GK
Atherosclerosis; 2016 Mar; 246():1-6. PubMed ID: 26745182
[TBL] [Abstract][Full Text] [Related]
29. Familial hypercholesterolemia: an under-recognized but significant concern in cardiology practice.
Foody JM
Clin Cardiol; 2014 Feb; 37(2):119-25. PubMed ID: 24193792
[TBL] [Abstract][Full Text] [Related]
30. [Two forms of familial hypercholesterolemia: differences in cardiovascular risk factors, cardiac and extracardiac atherosclerosis].
Vogt A; Keller C; Heigl C; Weiss N; Zöllner N
Dtsch Med Wochenschr; 2014 Dec; 139(50):2573-7. PubMed ID: 25126774
[TBL] [Abstract][Full Text] [Related]
31. CaRe high - Cascade screening and registry for high cholesterol in Germany.
Schmidt N; Grammer T; Gouni-Berthold I; Julius U; Kassner U; Klose G; König C; Laufs U; Otte B; Steinhagen-Thiessen E; Wanner C; März W
Atheroscler Suppl; 2017 Nov; 30():72-76. PubMed ID: 29096864
[TBL] [Abstract][Full Text] [Related]
32. Single Nucleotide Variants Associated With Polygenic Hypercholesterolemia in Families Diagnosed Clinically With Familial Hypercholesterolemia.
Lamiquiz-Moneo I; Pérez-Ruiz MR; Jarauta E; Tejedor MT; Bea AM; Mateo-Gallego R; Pérez-Calahorra S; Baila-Rueda L; Marco-Benedí V; de Castro-Orós I; Cenarro A; Civeira F
Rev Esp Cardiol (Engl Ed); 2018 May; 71(5):351-356. PubMed ID: 28919240
[TBL] [Abstract][Full Text] [Related]
33. Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: Importance of early detection and lifestyle advice.
Pang J; David Marais A; Blom DJ; Brice BC; Silva PR; Jannes CE; Pereira AC; Hooper AJ; Ray KK; Santos RD; Watts GF
Atherosclerosis; 2018 Oct; 277():470-476. PubMed ID: 30270087
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein B Arg3500Gln mutation prevalence in children with hypercholesterolemia: a French multicenter study.
Viola S; Benlian P; Morali A; Dobbelaere D; Lacaille F; Rieu D; Ginies JL; Maurage C; Meyer M; Lachaux A; Larchet M; Lenearts C; Goulet O; Sarles J; Mouterde O; Girardet JP;
J Pediatr Gastroenterol Nutr; 2001 Aug; 33(2):122-6. PubMed ID: 11568510
[TBL] [Abstract][Full Text] [Related]
35. Knowledge gaps in the management of familial hypercholesterolaemia. A UK based survey.
Schofield J; Kwok S; France M; Capps N; Eatough R; Yadav R; Ray K; Soran H
Atherosclerosis; 2016 Sep; 252():161-165. PubMed ID: 27451004
[TBL] [Abstract][Full Text] [Related]
36. [Homozygous familial hypercholesterolemia: development and a case illustration].
Choukri M; Laaroussi N; Taheri H; Chabraoui L
Ann Biol Clin (Paris); 2013; 71(1):99-103. PubMed ID: 23396432
[TBL] [Abstract][Full Text] [Related]
37. Familial hypercholesterolemia: experience from France.
Rabès JP; Béliard S; Carrié A
Curr Opin Lipidol; 2018 Apr; 29(2):65-71. PubMed ID: 29389714
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and management of familial hypercholesterolemia in patients with coronary artery disease: The heredity survey.
Faggiano P; Pirillo A; Griffo R; Ambrosetti M; Pedretti R; Scorcu G; Werren M; Febo O; Malfatto G; Favretto G; Sarullo F; Antonini-Canterin F; Zobbi G; Temporelli P; Catapano AL;
Int J Cardiol; 2018 Feb; 252():193-198. PubMed ID: 29249427
[TBL] [Abstract][Full Text] [Related]
39. Identifying patients with familial hypercholesterolemia using data mining methods in the Northern Great Plain region of Hungary.
Paragh G; Harangi M; Karányi Z; Daróczy B; Németh Á; Fülöp P
Atherosclerosis; 2018 Oct; 277():262-266. PubMed ID: 30270056
[TBL] [Abstract][Full Text] [Related]
40. [Familial hypercholesterolemia: An under-diagnosed and under-treated disease. Survey of 495 physicians].
Béliard S; Rabès JP; Cariou B; Farnier M; Krempf M; Ferrières J; Danchin N; Bruckert E
Presse Med; 2018 Sep; 47(9):e159-e167. PubMed ID: 30060905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
